Azenta (AZTA) Current Leases (2014 - 2024)

Azenta's (AZTA) quarterly Current Leases came in at $10.7 million in Q2 2024, down 0.58% quarter-over-quarter from $10.8 million in Q1 2024.

Analysis

Azenta (AZTA) Current Leases (2014 - 2024) Analysis & Trends

Azenta (AZTA) has reported Current Leases for 4 consecutive years, with $10.7 million the latest figure, recorded in Q2 2024.

On a quarterly basis, Current Leases changed N/A year-over-year to $10.7 million in Q2 2024; TTM through Jun 2024 was $10.7 million, a N/A change from a year earlier, with the FY2023 full-year figure at $9.5 million, changed N/A from the prior year.
Current Leases was $10.7 million for Q2 2024 at Azenta, down from $10.8 million in the prior quarter.
Over five years, Current Leases peaked at $10.8 million in Q1 2024 and troughed at $9.5 million in Q3 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Thermo Fisher Scientific	223.99 Bn	219.93 Bn	8.34 Bn	-
2	Danaher	141.56 Bn	137.22 Bn	3.61 Bn	-
3	Agilent Technologies	40.36 Bn	38.60 Bn	1.04 Bn	-
4	Illumina	30.41 Bn	29.24 Bn	770.00 Mn	-
5	Revvity	13.50 Bn	12.48 Bn	416.87 Mn	-
6	Bio-Techne	11.25 Bn	10.98 Bn	211.39 Mn	14.94 Mn
7	Bio-Rad Laboratories	9.88 Bn	8.26 Bn	345.80 Mn	33.60 Mn
8	Repligen	9.29 Bn	8.28 Bn	110.04 Mn	19.32 Mn
9	10x Genomics	8.62 Bn	8.06 Bn	112.50 Mn	12.02 Mn
10	Azenta	1.37 Bn	1.04 Bn	198.10 Mn	-

Historic Data

Download Data